NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
Clinical Trials
6 trialsNCT05016622 2024-07-31
Booster Dose Trial
Montefiore Medical Center
Phase 2 Terminated
NCT05075538 2024-01-17
I-SPARC
Jules Bordet Institute
Phase 4 Terminated
NCT04951323 2022-05-18
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
University of Liege
Phase 3 Unknown
NCT04743388 2022-04-11
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
National and Kapodistrian University of Athens
Unknown
NCT05119738 2022-02-02
Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment
Pontificia Universidad Catolica de Chile
Unknown